Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas

Authors

Keywords

Journal

Volume 22, Issue 4, Pages 506-523

Publisher

Elsevier BV

Online

2012-10-16

DOI

10.1016/j.ccr.2012.09.003

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now